We serve Chemical Name:1,2-diiodotetrafluorobenzene CAS:2708-97-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1,2-diiodotetrafluorobenzene
CAS.NO:2708-97-6
Synonyms:EINECS 220-303-3;MFCD00019011;perfluoro-1,2-diiodobenzene;1,2,3,4-Tetrafluorodiiodobenzene;1,2-Diiodotetrafluorobenzene;o-diiodotetrafluorobenzene;1,6-diiodo-tetrafluoro-benzene;1,2-diiodo-3,4,5,6-tetrafluorobenzene
Molecular Formula:C6F4I2
Molecular Weight:401.86700
HS Code:2903999090
Physical and Chemical Properties:
Melting point:49-50 °C(lit.)
Boiling point:232.6ºC at 760 mmHg
Density:2.671 g/cm3
Index of Refraction:1.608
PSA:
Exact Mass:401.80300
LogP:3.45220
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like EINECS 220-303-3 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,2-diiodo-3,4,5,6-tetrafluorobenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,2,3,4-Tetrafluorodiiodobenzene Use and application,1,6-diiodo-tetrafluoro-benzene technical grade,usp/ep/jp grade.
Related News: The Japanese drugmaker is injecting $126 million into its Thousand Oaks facility to boost manufacturing and support new product lines, Pacific Coast Business Times first reported. Takeda was joined by the city’s mayor, Claudia Bill-de la Peña, for a groundbreaking event on Thursday, July 22. 3-(2-tetraoxidaneyl-13,24,34,43,53,63-hexaoxin-3-yl)-13,23,34,43,53,64,73,83,94-pentaoxolo[4,5]hexaoxin-6-ol manufacturers Zynteglo, a gene therapy for the blood disorder beta thalassaemia, uses a viral vector (or modified virus) to deliver a working gene into the patient’s blood cells. 1,2-bis(3,4-dimethoxyphenyl)pentane-1,5-diol (en)1,5-Pentanediol, 1,2-bis(3,4-dimethoxyphenyl)- (en) suppliers Many specialty and biotech organizations are now relying on external service providers to minimize the costs of manufacturing and in-house development required to develop molecules for new drugs and their subsequent clinical trials, explains Saurabh Gurnurkar, executive director, UQUIFA. Glycerin-α-propylaether-bis-(naphthyl-(1)-urethan) vendor & factory.
